Skip to main content
Fig. 3 | Breast Cancer Research

Fig. 3

From: HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer

Fig. 3

Inter- and intra-patient CTC and tdEV heterogeneity (a) and association with clinical outcome (b). The numbers of patients with the respective CTC (left) and tdEV (right) classes present in their blood are shown as numbers in the corresponding parts of the Venn diagrams (a). For a tdEV class to be considered present, a threshold of 10 tdEV counts was used. Patients with uniform CTC and tdEV immunophenotypes (1 class) have a better prognosis compared to patients with more heterogeneous CTC and tdEV immunophenotypes (2 or 3 classes) present (b)

Back to article page